i
Suggested Reporting Language, Interpretation and Guidance Regarding Lyme Disease Serologic Test Results
-
MAY 2021
[PDF-1.26 MB]
Details:
-
Alternative Title:APHL Suggested Reporting Language, Interpretation and Guidance Regarding Lyme Disease Serologic Test Results |
-
Corporate Authors:
-
Description:Lyme disease, predominantly caused by Borrelia burgdorferi (also referred to as Borreliella burgdorferi), is currently the most common tick-borne illness in North America. In 2017, over 40,000 confirmed or probable Lyme disease cases were reported to the US Centers for Disease Control and Prevention (CDC). The true incidence of this disease, however, is estimated to be 8-10 times higher, with greater than 5 million diagnostic tests being performed every year. Diagnosis of Lyme disease is reliant on both a clinical suspicion of disease and on appropriate utilization of diagnostic tests, including serologic assays for detection of an immune response to infection with B. burgdorferi. The recommended serologic testing algorithms involve multiple tests, and correct result interpretation depends on the timing of testing relative to symptom onset and disease manifestation.
This project was 100% funded with federal funds. The training series was supported by Cooperative Agreement # NU60OE000104 funded by the Centers for Disease Control and Prevention (CDC). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of CDC or the Department of Health and Human Services.
ID-2021-Lyme-Disease-Serologic-Testing-Reporting.pdf
-
Subjects:
-
Document Type:
-
Funding:
-
Place as Subject:
-
Pages in Document:16 numbered pages
-
Collection(s):
-
Main Document Checksum:
-
Download URL:
-
File Type:
